WallStreetZenWallStreetZen

NASDAQ: OTLK
Outlook Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Outlook Therapeutics earnings were -$43.4M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest OTLK earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$20.2M, down 56.5% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, OTLK reported annual earnings of -$75.4M, with 27.8% growth.

OTLK earnings history

Current Revenue
$1.5M
Current Earnings
-$43.4M
Current Profit Margin
-2,885.8%

OTLK Return on Equity

Current Company
N/A
Current Industry
-9.6%
Current Market
32.4%

OTLK undefined

Current Company
-199.1%
Current Industry
0%
OTLK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when OTLK announces earnings.

OTLK undefined

Current Company
476.73%
Current Industry
7.8%
OTLK has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

OTLK vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
OTLK-$43.25M-$43.44MN/A-$0.57
XBIT-$25.88M-$28.16MN/A-$0.92
TCRX-$130.55M-$136.78MN/A-$1.09
IVVD-$106.82M-$110.13MN/A-$0.92
HLVX-$66.58M-$71.10MN/A-$1.44
View Top Biotech Stocks

Outlook Therapeutics Earnings Reports & History FAQ

What were Outlook Therapeutics's earnings last quarter?

Outlook Therapeutics (NASDAQ: OTLK) reported Q2 2025 earnings per share (EPS) of -$0.55, up 128.8% year over year. Total OTLK earnings for the quarter were -$20.15 million. In the same quarter last year, Outlook Therapeutics's earnings per share (EPS) was $1.91.

If you're new to stock investing, here's how to buy Outlook Therapeutics stock.

Is Outlook Therapeutics profitable or losing money?

As of the last Outlook Therapeutics earnings report, Outlook Therapeutics is currently losing money. Outlook Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$43.44 million, a 53.81% decrease year over year.

What was OTLK's earnings growth in the past year?

As of Outlook Therapeutics's earnings date in Q3 2025, Outlook Therapeutics's earnings has grown year over year. OTLK earnings in the past year totalled -$43.44 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.